Decision Support Tool for Patients With Advanced Breast Cancer
Communicating Options for Advanced Breast Cancer Support and Treatment (COAST)
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Procedures mentioned: Questionnaires, Interviews
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "Participants will be asked to fill out two surveys: one before they use the COAST tool and another about 2 - 4 weeks later."
- "Some patients will also be invited for an interview."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests COAST, a tool to help adults with advanced breast cancer talk with their cancer care team and make care decisions together. Researchers want to learn if it improves these talks and is easy to use. Participants will fill out two surveys, about 2–4 weeks apart, and some may be invited for an interview.
The goal of this pilot study is to understand and improve the shared decision-making process between people with advanced breast cancer and their providers regarding their care and treatment. As part of this study, the researchers will evaluate a decision support tool called COAST that was designed to support patients and providers in having meaningful conversations. The main questions it aims to answer are: 1. Can the COAST tool improve the quality of communication between patients and their oncology providers? 2. Is the COAST tool acceptable, appropriate, and easy to use at NYP-Weill Cornell Medicine, NYP-Brooklyn Methodist Hospital and NYP-Queens? Participants will be asked to fill out two surveys: one before they use the COAST tool and another about 2 - 4 weeks later. Some patients will also be invited for an interview.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Age 18 or older, male or female.
- Have stage IV breast cancer, which has spread to distant parts of the body.
- Speak English, Spanish, or Mandarin.
Who can't join
- Have early-stage breast cancer.
- Have a main language other than English, Spanish, or Mandarin.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Male or female 18 years and older * Diagnosis of Stage IV breast cancer * English, Spanish or Mandarin speaking Exclusion Criteria: * Early breast cancer * Individuals speaking languages other than English, Spanish, or Mandarin as their primary language
Study sites (3)
NY
- NewYork-Presbyterian Brooklyn Methodist Hospital · Brooklyn, NY 11215Zori K Hamilton, MA · Study contact · 6469623694 · zkh4001@med.cornell.eduEvelyn Taiwo, MD · Principal investigatorMore trials in Brooklyn
- NewYork-Presbyterian Medical Group Queens · Flushing, NY 11355Zori K Hamilton, MA · Study contact · 646-962-3694 · zkh4001@med.cornell.eduPooja Murthy, MD · Principal investigatorMore trials in Flushing
- NewYork-Presbyterian David H. Koch Center · New York, NY 10065Zori K Hamilton, MA · Study contact · 646-962-3694 · zkh4001@med.cornell.eduShoshana Rosenberg, ScD, MPH · Principal investigatorMore trials in New York